Systemic therapy for advanced adrenal cancer

Journal of Surgical Oncology, 04/09/2012

Dreice R – The systemic management of advanced adrenal cancer remains a major therapeutic dilemma as it is both highly resistant to systemic agents and very rare epithelial neoplasm making clinical investigation a significant challenge. The role of mitotane, systemic chemotherapy and novel targeted agents are reviewed.

Print Article Summary Cat 2 CME Report